What a fantastic six months it’s been for BrightSpring Health Services. Shares of the company have skyrocketed 47.6%, hitting $61.14. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
Is it too late to buy BTSG? Find out in our full research report, it’s free.
Why Does BTSG Stock Spark Debate?
Founded in 1974, BrightSpring Health Services (NASDAQ: BTSG) offers home health care, hospice, neuro-rehabilitation, and pharmacy services.
Two Things to Like:
1. Skyrocketing Revenue Shows Strong Momentum
A company’s long-term sales performance is one signal of its overall quality. Any business can put up a good quarter or two, but many enduring ones grow for years. Over the last five years, BrightSpring Health Services grew its sales at an impressive 20.2% compounded annual growth rate. Its growth surpassed the average healthcare company and shows its offerings resonate with customers.
2. Projected Revenue Growth Is Remarkable
Forecasted revenues by Wall Street analysts signal a company’s potential. Predictions may not always be accurate, but accelerating growth typically boosts valuation multiples and stock prices while slowing growth does the opposite, though some deceleration is natural as businesses become larger.
Over the next 12 months, sell-side analysts expect BrightSpring Health Services’s revenue to rise by 14.1%. While this projection is below its 23.9% annualized growth rate for the past two years, it is particularly healthy for a company of its scale and suggests the market is baking in success for its products and services.
One Reason to Be Careful:
Mediocre Free Cash Flow Margin Limits Reinvestment Potential
Free cash flow isn’t a prominently featured metric in company financials and earnings releases, but we think it’s telling because it accounts for all operating and capital expenses, making it tough to manipulate. Cash is king.
BrightSpring Health Services has shown mediocre cash profitability relative to peers over the last five years, giving the company fewer opportunities to return capital to shareholders. Its free cash flow margin averaged 1.3%, below what we’d expect for a healthcare business.
Final Judgment
BrightSpring Health Services has huge potential even though it has some open questions, and with the recent surge, the stock trades at 28.3× forward P/E (or $61.14 per share). Is now the time to buy despite the apparent froth? See for yourself in our in-depth research report, it’s free.
High-Quality Stocks for All Market Conditions
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.
